In 2010 the estimated global burden of mental and behavioral disorders in terms of the number of years lived with the disability, was approximately 23%. Today, based on published data, we believe it accounts for over 30% of the global burden of diseases. Despite the social and human impact, the estimated loss of output by non-communicable diseases is mind-blowing, with mental illnesses alone accounting for an estimated $17 trillion.
350 million people globally suffer from depression alone.
Studies show that Lactobacillus plantarum can cause positive changes in emotional behaviours and significantly reduce anxiety-like behaviours.
Researchers have concluded that Lactobacillus plantarum has psychotropic properties without physical side effects, and has great potential for treating neuropsychiatric disorders, including anxiety.
The present invention indicates that it can provide an advantageous effect in the treatment or prevention of circulatory disorders and basal ganglia disorders, such as, Parkinson’s disease, Tourette syndrome, unilateral convulsions, dystonia, psychostimulant addiction, Huntington’s disease, and OCD.
Lactobacillus plantarum is commonly found in many fermented vegetables including sauerkraut, pickles, brined olives, kimchi.
As part of our ongoing fight against this disease, we continue to explore novel, evidence-based products and concepts; working with like-minded inventors and partners to get the right treatments to the people in need, when they need them.
Currently, we are focusing on products in the following areas.